Zenagamtide
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semagl
Novo Nordisk · Phase 1 · Recruiting · Enrollment 60
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.